Results 181 to 190 of about 1,731,278 (307)

The Supporting Role of Natural Products as Effective Adjuvants in Cancer Immunotherapy

open access: yeseFood, Volume 7, Issue 3, June 2026.
Natural products, as multi‐target and low‐toxicity adjuvants, enhance immune checkpoint inhibitor responses and reduce immune‐related adverse events through T cell reprogramming, microenvironment remodeling, and microbiota‐immune modulation. ABSTRACT Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of malignant tumors ...
Boyang Liu   +6 more
wiley   +1 more source

Development of lamprey-derived antibodies against human blood group antigens. [PDF]

open access: yesGlycobiology
Kunz PB   +7 more
europepmc   +1 more source

Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1985
M. Błaszczyk   +4 more
semanticscholar   +1 more source

Relationship between ABO blood group and lymph node metastasis in colon cancer: a retrospective cohort study. [PDF]

open access: yesWorld J Surg Oncol
Ramírez-Giraldo C   +7 more
europepmc   +1 more source

Biosynthesis of ABH and Lewis antigens in normal and transplanted kidneys.

open access: yesTransplantation, 1980
R. Oriol   +3 more
semanticscholar   +1 more source

Vacuolization as a Novel Approach to Cancer Therapy

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 6, June 2026.
This review discusses the novel strategy of inducing vacuole formation in cancer cells using small molecules, that induce nonapoptotic cell death mechanisms, such as paraptosis, oncosis, autophagy, and methuosis, and its potential in overcoming resistance to apoptosis‐based cancer therapies.
Mariah Pasternak   +9 more
wiley   +1 more source

Integrative Approach to Develop and Characterize Antibodies against the Cancer-Associated Antigen Sialyl Lewis A (CA 19-9). [PDF]

open access: yesJACS Au
Freitag A   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy